{"name":"scPharmaceuticals, Inc.","slug":"scpharmaceuticals-inc","ticker":"","exchange":"","domain":"scpharmaceuticals.com","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"Pharma / Biotech","status":"active","statusNote":"","leadDrug":"","leadIndication":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Other","slug":"other","revenue":0,"percentOfTotal":0,"drugCount":2,"colorKey":"oncology","drugs":[{"name":"Furosemide USP","genericName":"Furosemide USP","slug":"furosemide-usp","indication":"Other","status":"phase_1"},{"name":"SCP-111","genericName":"SCP-111","slug":"scp-111","indication":"Other","status":"phase_1"}]}],"pipeline":[{"name":"Furosemide USP","genericName":"Furosemide USP","slug":"furosemide-usp","phase":"phase_1","mechanism":"Small molecule","indications":[],"catalyst":""},{"name":"SCP-111","genericName":"SCP-111","slug":"scp-111","phase":"phase_1","mechanism":"Small molecule","indications":[],"catalyst":""}],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMivgFBVV95cUxQeW5OTHFLcmd5NC1uRmtWZjl2MmUyTTV3YXdXNWxMc194aWc2Tm5vU01PVHJDYnFPQXFhSDJEMVpCcE1OWUhTVGtiNk5SZ0FFNV80T3RtSnVWcm5mRGdpc2MybU4tSHRabFUyOFdFLVV2TXllNGF5eHJLUFRKeFZURUJ6QTRBQVVSUHlvYjR2c2hEeDNXNVV0eXBXRExYT2ZiYks0bFN3UXBiSlBPMm1Lb2p1Qktkb1ptaGJwMUx3?oc=5","date":"2025-10-07","type":"pipeline","source":"Stock Titan","summary":"Over $370M Annualized Run Rate — MannKind Completes Acquisition of scPharmaceuticals; $5.35 Cash - Stock Titan","headline":"Over $370M Annualized Run Rate — MannKind Completes Acquisition of scPharmaceuticals; $5.35 Cash","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiiAFBVV95cUxNb3lzTlBBVG0tNFMyZEJUcVFkTVVOakx4eFVJeHNKOWVCblB3ZWJjbXVXVy1TQXprYy1SakI5QTdhT3N0TmJNR3RaVG9qMzY5bDB5c0kza2JFSkpaMEo0djVfUklreEZUUEtGUnJlRG5JZjhMREgtS1JfUk1ZNC1tY1VoUFBwaEl4?oc=5","date":"2025-08-26","type":"deal","source":"The Pharma Letter","summary":"MannKind to acquire scPharmaceuticals - The Pharma Letter","headline":"MannKind to acquire scPharmaceuticals","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi_wFBVV95cUxQOC1wZ2x4cUdzel8teFpwc0JTQTBaS0dIdUl2ZzNSRW5ZTnU0dGxrX2ZfZ3FjMlVxV3NPUFBtS1hmTEthOVhQcEJxT2ZHNENBMEtWZ0tCN1ZtWFVhM0RvYV94bU1DdkRiS2VQZEZPUTlmdTQ4V1FDNEhBdWZpRkRSWGpTc1FxdFpONkZ4MGpfTDdrNTE3VHE4Y2JiRkhRazhDRXJZNHBZZVJNaWdhcHZnMGJjaVJMblpIZk5RaGZKX1NHNnRmTkVhbG5ZNnFzbWlTaGI4RmZxeWxvNzc0bTFkV0paejBsRnZHOGJxNkR5dUxOeGh4Uk1zNzh5U3kxMVU?oc=5","date":"2025-08-26","type":"deal","source":"Stocktwits","summary":"MannKind’s $360M scPharma Deal Splits Analysts — Retail Traders Call It ‘Bizarro Territory’ But Stay Bullish - Stocktwits","headline":"MannKind’s $360M scPharma Deal Splits Analysts — Retail Traders Call It ‘Bizarro Territory’ But Stay Bullish","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiuAFBVV95cUxNV3dmZExzOVNFcUtPMV94d3RUVWNGQUM5X2ZLVUVndGFPVGEyQU55NzM5eXRIMWg1RnQyV2V4clEzV3pVVy1aOGtzc0I0OG5MeVlJc29EWlFaSHQyS2NZS29GNmxEM0t1Q1VxMHVfQVpYM2RFRlYySV8tUjJXLWJJUVVfWTRLWjYtQ2ZxUWpIUThiTC1meGFIOFNVa2htZ1FnTlF6X0Rzd0hua1dSaFVtZWlvdGs4cE9Z?oc=5","date":"2025-08-25","type":"deal","source":"Fierce Pharma","summary":"MannKind grabs scPharmaceuticals and its heart failure infuser Furoscix in $360M deal - Fierce Pharma","headline":"MannKind grabs scPharmaceuticals and its heart failure infuser Furoscix in $360M deal","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMijgFBVV95cUxPMENhU28yc2xsQ2c4WHFOVVFUV2QxN1R6YXNidUdYYTlUb2JCM0RzLXA1UGVZelZYbWdnWVBfaVY1OTl5bXpXTm1SNC1EX2YzSjRkMGo4Nm9jOHI3bTVrN2JWcFlNaGdVclRpTHJBTDBQX0swZGhES0xxSThTQTFyWC1JMXF3YUxyMmVSZm9B?oc=5","date":"2025-07-09","type":"earnings","source":"Yahoo Finance","summary":"scPharmaceuticals Inc.'s (NASDAQ:SCPH) Shift From Loss To Profit - Yahoo Finance","headline":"scPharmaceuticals Inc.'s (NASDAQ:SCPH) Shift From Loss To Profit","sentiment":"neutral"},{"url":"https://news.google.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?oc=5","date":"2025-05-27","type":"pipeline","source":"simplywall.st","summary":"Shareholders Will Likely Find scPharmaceuticals Inc.'s (NASDAQ:SCPH) CEO Compensation Acceptable - simplywall.st","headline":"Shareholders Will Likely Find scPharmaceuticals Inc.'s (NASDAQ:SCPH) CEO Compensation Acceptable","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMipgFBVV95cUxNbjkyOGdjenhOUVRXeVVJN19BbXpuYVFhc0ZJN3o0b3Z6R0VhNEVBSkdEYy1pQjRIMXVHeFBmN0R6S2lGNHhCQUExaTdGdHlxcy1aTXJFMTdQU3pfMmU5SU1TSGdXNlNvY3FKNFJBbDMycHM0U3F5bzRCblkxRENlZTlYRHZXalVPSVFaQl9uWUR1dDJxX18tajYzVUxrdHZmUlhWTWdB?oc=5","date":"2025-05-22","type":"pipeline","source":"Seeking Alpha","summary":"scPharmaceuticals: Furoscix Sales To Accelerate Throughout 2025 - Seeking Alpha","headline":"scPharmaceuticals: Furoscix Sales To Accelerate Throughout 2025","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiugFBVV95cUxORHBNWl9HMmQ1bUtIbi14ZkdYb0RoenhvS3JGWGdoclRZdVY5d1Nld1h6YzlMUGpuU2tmMDJqYW02N2JUSjRiMlBxdEtTMURYZ1ZJcTlsLUo1WnFmUjNaeFdPRnhzQzYxb0hlaWlYMEJuV2tfaDdodUktWXhLaFVRSDdNVUd3ckJVcGYzMnBOdnFuRGQyb3BMSnhpRnpWYnNBTU9RQnlBWWtJZkFUYVhTOTBjbUppb3ZRdFE?oc=5","date":"2025-03-06","type":"regulatory","source":"Pharmacy Times","summary":"FDA Approves Expansion for Furosemide Injection to Treat Edema In Patients With CKD - Pharmacy Times","headline":"FDA Approves Expansion for Furosemide Injection to Treat Edema In Patients With CKD","sentiment":"positive"},{"url":"https://news.google.com/rss/articles/CBMihgJBVV95cUxNbERWNGZZYW91Tk5ZZHRLWk5PRFVndm5iY20yNUJ3cFd5V1owYTFGaUg5V1ladkdiOGtNN2J6VFJVdTBVQ3JTSnZXU1o4UG9adWduNklYYmxiVU5zOFdoRkUtbi1IdUI3NC1nQ0JfVGxBRGtPN0w3SnNNdU0tNm9vZ29qVFlBaV9wb0w1Z1VWWFVLb2RrS0VOM3ZxS0JISUVWN1FseEtqM3FoYlBqeHFQOGg3SVlNZU9ramRNdi1SODdEcnRVWDB6NjVVaDJVR2FzMTZhc2hUVkliTGRvWjRhTVQ2aS1FWllZdHJJTVN3cHJLU205VVhRT0tRLTRqWmZGVG1HcGpR?oc=5","date":"2024-08-12","type":"pipeline","source":"GlobeNewswire","summary":"scPharmaceuticals Announces Non-Dilutive Financings Totaling Up to $125 Million with Perceptive Advisors - GlobeNewswire","headline":"scPharmaceuticals Announces Non-Dilutive Financings Totaling Up to $125 Million with Perceptive Advisors","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMilAFBVV95cUxPYzBsY2ZFRGFIRGdIRElJOFRXS3BrdlJNTXJ2aVZDcWp0Wkd5ZWlUZ2ZFSTFrT1FrRUJjTlNrNTlZZERfR09vbnYyZVRYa2pQbXdDYUJyd0JaQ1NZSGNSeS03WE40cWF5SWhBQVVuWVBDejg5TjNGeEdrZVFneU5ja2VvRmNQdTZSdVE1RFV1enR2X0ND?oc=5","date":"2024-03-13","type":"earnings","source":"Yahoo Finance","summary":"scPharmaceuticals Inc. Reports Fourth Quarter and Full-Year 2023 Financial Results and Provides Business Update - Yahoo Finance","headline":"scPharmaceuticals Inc. Reports Fourth Quarter and Full-Year 2023 Financial Results and Provides Business Update","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMixgFBVV95cUxNZjV6MEF3c045RXNjVnc0RE1nSGlsZ0VsakRpNzd0RHQ4OUhfT3E0NlE3eHVweldlZm02bHBhNW9IZzJnNGRqNFpPdUg5UEU4dnNhVHpBOW9DM2VDSjM2RWZDUUlBVHR5bXZWSVNDZ2sxT1hUc0JsOTZfY2swWV81MVpEM1dMem1INGJDOC1BSVhYUWNWaWJ6dnNGNGI4b0xsU2pJb0dCVTE0UENNNGdyYnlKNU9GNVMtaDA4OWpkRmU2Q2FfNVE?oc=5","date":"2022-07-19","type":"trial","source":"dicardiology.com","summary":"scPharmaceuticals Inc. Announces Positive Results from the AT HOME-HF Phase 2 Pilot Study in Heart Failure - dicardiology.com","headline":"scPharmaceuticals Inc. Announces Positive Results from the AT HOME-HF Phase 2 Pilot Study in Heart Failure","sentiment":"negative"},{"url":"https://news.google.com/rss/articles/CBMiwwFBVV95cUxNQko3c0ZJWGg4WFUzSFVkLVUyaXU2S1NpUGFKd3JENzJUSlAtdXJ2MUU0QnR4Rmdpb2RBN1hXM2ljXzFhaEk0RnlqRGY5bWZWYk5Mb1J2QzNsZjJ5UkFCYkxlbktRNnpYMnZVVm5xYkxHUTg5T1BHWnBLN0ItXzQ2bUpzbXVhN0ZUWUJSOVVmbHVvRjhTUFRLeG1TUXVIa09KaWZnMVRISmV5aG5XX25WRHNMclhGdHhJbEtiTmpnbVpMLTA?oc=5","date":"2017-04-26","type":"pipeline","source":"prnewswire.com","summary":"John Tucker appointed as Chief Executive Officer of scPharmaceuticals - prnewswire.com","headline":"John Tucker appointed as Chief Executive Officer of scPharmaceuticals","sentiment":"neutral"}],"patents":[],"drugCount":2,"phaseCounts":{"phase_1":2},"enrichmentLevel":0,"visitCount":4,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}